Test demonstrated high performance metrics in largest study of its kind in the US with sensitivity of 100% and specificity of 99.3% Natera’s study is the largest clinical validation of a fetal RhD ...

Patient sleeps with the patient-applied Onera home Polysomnography (Onera hPSG) solution. The international multicenter study ...

Study demonstrates comparable performance between wireless, patch-based Onera Sleep Test System and in-lab polysomnography for sleep staging and respiratory event detection. EINDHOVEN, ...

The PREVENT equations from the American Heart Association (AHA) accurately predict 10-year risk of mortality related to cardiovascular disease in the US general population, according to an external ...

Producing cGMP biopharmaceutical products requires controlled, consistent performance of the manufacturing process. cGMP also requires controlled, consistent performance of analytical test methods.

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the publication of two major studies, DTRT-2 and Trifecta-Heart, ...

Biodesix, Inc. announced a new study published in CHEST Pulmonary Journal reaffirming the effectiveness of its Nodify CDT® blood-based lung nodule test, which assesses seven autoantibodies linked to ...

An announcement from Blinklab Limited ( ($AU:BB1) ) is now available. BlinkLab has secured a significant validation of its technology with the ...

NEW YORK, NY, UNITED STATES, January 9, 2026 /EINPresswire.com/ — Sinansys, a next-generation supply chain resilience ...